Background:Patients at ultra-high risk for psychosis (UHR) are a highly heterogeneous group in terms of clinical and functional outcomes. Several non-psychotic mental disorders co-occur together with the UHR state. Little is known about the impact of non-psychotic comorbid mental disorders on clinical and functional outcomes of UHR patients.Methods:The sample included 154 UHR help-seeking patients (identified with the CAARMS, Comprehensive Assessment of the At-Risk Mental State), evaluated at baseline on the Ham-D, Ham-A (Hamilton Depression/Anxiety Rating Scale), and PANSS (Positive and Negative Syndrome Scale). 74 patients completed the 6-year follow-up assessment (mean=6.19, SD=1.87). Comorbid disorders at follow-up were assessed with th...
Background: Neurocognitive impairments are a core feature of schizophrenia (ScZ) contributing to ong...
Background Acute and transient psychotic disorders (ATPD) are characterized by an acute onset and a ...
More than 20 years after the clinical high risk syndrome for psychosis (CHR) was first articulated, ...
Background:Patients at ultra-high risk for psychosis (UHR) are a highly heterogeneous group in terms...
BACKGROUND: Patients at ultra-high risk for psychosis (UHR) are a highly heterogeneous group in ter...
© 2019 Anneliese Elizabeth Spiteri-StainesBackground: Despite there being a large body of research a...
OBJECTIVE: Two-thirds of individuals identified as at ultra-high risk for psychosis do not develop p...
Diagnoses of anxiety and/or depression are common in subjects at Ultra-High Risk for Psychosis (UHR)...
More than 20 years after the clinical high risk syndrome for psychosis (CHR) was first articulated, ...
Background: The long-term functional status of subjects at ultra high risk for psychosis (HR) is rel...
Background: To determine the 2-year clinical and functional outcomes of an Asian cohort at ultra-hig...
International audienceIntroduction: Diagnoses of anxiety and/or depression are common in subjects at...
Emerging evidence suggests that the duration of risk symptoms (DUR) may have an impact on clinical o...
Background: Little is known about clinical outcomes other than transition to psychosis in people at ...
The main focus of research on clinical high-risk states for psychosis (CHR) has been the development...
Background: Neurocognitive impairments are a core feature of schizophrenia (ScZ) contributing to ong...
Background Acute and transient psychotic disorders (ATPD) are characterized by an acute onset and a ...
More than 20 years after the clinical high risk syndrome for psychosis (CHR) was first articulated, ...
Background:Patients at ultra-high risk for psychosis (UHR) are a highly heterogeneous group in terms...
BACKGROUND: Patients at ultra-high risk for psychosis (UHR) are a highly heterogeneous group in ter...
© 2019 Anneliese Elizabeth Spiteri-StainesBackground: Despite there being a large body of research a...
OBJECTIVE: Two-thirds of individuals identified as at ultra-high risk for psychosis do not develop p...
Diagnoses of anxiety and/or depression are common in subjects at Ultra-High Risk for Psychosis (UHR)...
More than 20 years after the clinical high risk syndrome for psychosis (CHR) was first articulated, ...
Background: The long-term functional status of subjects at ultra high risk for psychosis (HR) is rel...
Background: To determine the 2-year clinical and functional outcomes of an Asian cohort at ultra-hig...
International audienceIntroduction: Diagnoses of anxiety and/or depression are common in subjects at...
Emerging evidence suggests that the duration of risk symptoms (DUR) may have an impact on clinical o...
Background: Little is known about clinical outcomes other than transition to psychosis in people at ...
The main focus of research on clinical high-risk states for psychosis (CHR) has been the development...
Background: Neurocognitive impairments are a core feature of schizophrenia (ScZ) contributing to ong...
Background Acute and transient psychotic disorders (ATPD) are characterized by an acute onset and a ...
More than 20 years after the clinical high risk syndrome for psychosis (CHR) was first articulated, ...